VOLUME
66 2005 NUMBER 11
Commentary
1349 Hurricane Katrina: A Physician's Whirlwind Course in Disaster
Psychiatry. Shane Stephen Spicer
[PDF]
Original Articles
1351 The Epidemiology of Social Anxiety Disorder in the United States:
Results From the National Epidemiologic Survey on Alcohol and Related
Conditions. Bridget F. Grant, Deborah S. Hasin, Carlos Blanco, Frederick
S. Stinson, S. Patricia Chou, Rise B. Goldstein, Deborah A. Dawson, Sharon
Smith, Tulshi D. Saha, and Boji Huang
[Abstract]
[PDF]
1362 Efficacy of Aripiprazole Against Hostility in Schizophrenia and
Schizoaffective Disorder: Data From 5 Double-Blind Studies. Jan Volavka,
Pal Czobor, Leslie Citrome, Robert D. McQuade, William H. Carson, Dusan
Kostic, Sterling Hardy, and Ronald Marcus
[Abstract]
[PDF]
1367 Clinical Characteristics and Psychiatric Comorbidity in Males With
Exhibitionism. Jon E. Grant
[Abstract]
[PDF]
1372 Treatment of the Polydipsia-Hyponatremia Syndrome With Urea. Anne
Verhoeven, Wim Musch, and Guy Decaux
[Abstract]
[PDF]
1376 Typical and Atypical Antipsychotics in Bipolar Depression. Keming
Gao, Prashant Gajwani, Omar Elhaj, and Joseph R. Calabrese
[Abstract]
[PDF]
1386 QTc Interval Measurement and Metabolic Parameters in Psychiatric
Patients Taking Typical or Atypical Antipsychotic Drugs: A Preliminary
Study. Paul Mackin and Allan H. Young
[Abstract]
[PDF]
1392 Sequential Treatment of Mood and Anxiety Disorders.
[CME] Giovanni A. Fava, Chiara Ruini, and Chiara Rafanelli
[Abstract]
[PDF]
1401 The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of
Generalized Anxiety Disorder: Results of a Placebo-Controlled Study. Mark
H. Pollack, Peter P. Roy-Byrne, Michael Van Ameringen, Heather Snyder,
Charles Brown, John Ondrasik, and Karl Rickels
[Abstract]
[PDF]
1409 Residual Symptoms in Depressed Patients After Treatment With
Fluoxetine or Reboxetine. J. Craig Nelson, Laura Portera, and Andrew C.
Leon
[Abstract]
[PDF]
1415 Cognitive Therapy and Exposure in Vivo Alone and in Combination With
Fluvoxamine in Obsessive-Compulsive Disorder: A 5-Year Follow-Up.
Patricia van Oppen, Anton J. L. M. van Balkom, Else de Haan, and Richard van
Dyck
[Abstract]
[PDF]
1423 Naturalistic, Retrospective Comparison Between Second-Generation
Antipsychotics and Depot Neuroleptics in Patients Affected by Schizophrenia.
Livio Marchiaro, Paola Rocca, Ferdinando LeNoci, Pierpaolo Longo,
Cristiana Montemagni, Cristiana Rigazzi, and Filippo Bogetto
[Abstract]
[PDF]
1432 Misdiagnosed Patients With Bipolar Disorder: Comorbidities,
Treatment Patterns, and Direct Treatment Costs. Louis S. Matza, Krithika
S. Rajagopalan, Christine L. Thompson, and Gregory de Lissovoy
[Abstract]
[PDF]
1441 Safety and Efficacy of Escitalopram in the Long-Term Treatment of
Generalized Anxiety Disorder. Jonathan R. T. Davidson, Anjana Bose, and
Qin Wang
[Abstract]
[PDF]
1447 Variables Associated With Alcohol, Drug, and Daily Smoking Cessation
in Patients With Severe Mental Illnesses. [CME] Jose de Leon, Margaret T. Susce, Francisco J. Diaz, Diego M.
Rendon, and Diana M. Velásquez
[Abstract]
[PDF]
1456 Suicidal Ideation and Attempts in Bipolar I and II Disorders.
Hanna Valtonen, Kirsi Suominen, Outi Mantere, Sami Leppämäki, Petri
Arvilommi, and Erkki T. Isometsä
[Abstract]
[PDF]
1463 Undiagnosed Hyperglycemia in Patients Treated With Atypical
Antipsychotics. Michael J. Sernyak, Barbara Gulanski, and Robert
Rosenheck
[Abstract]
[PDF]
1468 Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine
in Combination With Fluoxetine for Major Depressive Disorder. Scott W.
Andersen, David B. Clemow, and Sara A. Corya
[Abstract]
[PDF]
Academic Highlights
1477 Untangling Depression and Anxiety: Clinical Challenges. [CME]
[PDF]
ASCP Corner
1488 Sexual Function and Dysfunction During Treatment With Psychotropic
Medications. Richard Balon
[PDF]
Letters To the Editor
1490 Clozapine-Induced Pericarditis, Pericardial Tamponade, Polyserositis,
and Rash. Moeen A. Bhatti, Janet Zander, and Elizabeth Reeve
[PDF]
1491 Applying Parsimony to "An African Patient With Ziprasidone
Intolerance." Jeffrey L. Anders
[PDF]
1492 Initial Evidence of the Beneficial Effects of Glutamate-Modulating
Agents in the Treatment of Self-Injurious Behavior Associated With
Borderline Personality Disorder. Christopher Pittenger, John H. Krystal,
and Vladimir Coric
[PDF]
1493 Orally Disintegrating Antipsychotics May Promote Compliance and
Adherence in Patients With Schizophrenia. Frank L. Tornatore
[PDF]
1494 Reexamining Paroxetine and Cognitive-Behavioral Therapy in
Postpartum Depression and Anxiety. Jennifer McClendon
[PDF]
- Reply by Shaila Misri, Pratibha Reebye, Maria Corral, and Lisa Milis
Book Reviews 1496 |